• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于淋巴结比率的分期系统在2575例胃癌患者预后预测中的优越性:大型单中心验证分析

Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.

作者信息

Zhao Lin-Yong, Li Chang-Chun, Jia Lu-Yu, Chen Xiao-Long, Zhang Wei-Han, Chen Xin-Zu, Yang Kun, Liu Kai, Wang Yi-Gao, Xue Lian, Zhang Bo, Chen Zhi-Xin, Chen Jia-Ping, Zhou Zong-Guang, Hu Jian-Kun

机构信息

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

Oncotarget. 2016 Aug 9;7(32):51069-51081. doi: 10.18632/oncotarget.9714.

DOI:10.18632/oncotarget.9714
PMID:27363014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5239459/
Abstract

This study aimed to evaluate the prognostic significance of node ratio (Nr), the ratio of metastatic to retrieved lymph nodes, and to investigate whether a modified staging system based on Nr can improve prognostic ability for gastric cancer patients following gastrectomy. A total of 2572 patients were randomly divided into training set and validation set, and the cutoff points for Nr were produced using X-tile. The relationships between Nr and other clinicopathologic factors were analyzed, while survival prognostic discriminatory ability and accuracy were compared among different staging systems by AIC and C-index in R program. Patients were categorized into four groups as follows: Nr0, Nr1: 0.00-0.15, Nr2: 0.15-0.40 and Nr3: > 0.40. Nr was significantly associated with clinicopathologic factors including macroscopic type, tumor differentiation, lymphovascular invasion, perineural invasion, tumor size, T stage, N stage and TNM stage. Besides, for all patients, Nr and TNrM staging system showed a smaller AIC and a larger C-index than that of N and TNM staging system, respectively. Moreover, in subgroup analysis for patients with retrieved lymph nodes < 15, Nr was demonstrated to have a smaller AIC and a larger C-index than N staging system. Furthermore, in validation analysis, Nr, categorized by our cutoff points, showed a larger C-index and a smaller AIC value than those produced in previous studies. Nr could be considered as a reliable prognostic factor, even in patients with insufficient (< 15) retrieved lymph nodes, and TNrM staging system may improve the prognostic discriminatory ability and accuracy for gastric cancer patients undergoing radical gastrectomy.

摘要

本研究旨在评估淋巴结转移率(Nr),即转移淋巴结与检出淋巴结的比值的预后意义,并探讨基于Nr的改良分期系统能否提高胃癌患者胃切除术后的预后预测能力。总共2572例患者被随机分为训练集和验证集,使用X-tile软件得出Nr的截断点。分析Nr与其他临床病理因素之间的关系,同时在R程序中通过AIC和C指数比较不同分期系统的生存预后判别能力和准确性。患者被分为以下四组:Nr0、Nr1:0.00 - 0.15、Nr2:0.15 - 0.40和Nr3:> 0.40。Nr与包括大体类型、肿瘤分化、淋巴管侵犯、神经周围侵犯、肿瘤大小、T分期、N分期和TNM分期在内的临床病理因素显著相关。此外,对于所有患者,Nr和TNrM分期系统的AIC分别比N分期系统和TNM分期系统小,C指数分别比它们大。而且,在检出淋巴结< 15的患者亚组分析中,Nr的AIC比N分期系统小,C指数比其大。此外,在验证分析中,按照我们的截断点分类的Nr的C指数比先前研究得出的大,AIC值比其小。即使在检出淋巴结不足(< 15)的患者中,Nr也可被视为可靠的预后因素,并且TNrM分期系统可能会提高接受根治性胃切除术的胃癌患者的预后判别能力和准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/3dde11ca5909/oncotarget-07-51069-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/4615f38a9047/oncotarget-07-51069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/94176d21b55c/oncotarget-07-51069-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/1312e55eb767/oncotarget-07-51069-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/d3fd2c078ba6/oncotarget-07-51069-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/881e20c76cc0/oncotarget-07-51069-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/3dde11ca5909/oncotarget-07-51069-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/4615f38a9047/oncotarget-07-51069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/94176d21b55c/oncotarget-07-51069-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/1312e55eb767/oncotarget-07-51069-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/d3fd2c078ba6/oncotarget-07-51069-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/881e20c76cc0/oncotarget-07-51069-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c0/5239459/3dde11ca5909/oncotarget-07-51069-g006.jpg

相似文献

1
Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.基于淋巴结比率的分期系统在2575例胃癌患者预后预测中的优越性:大型单中心验证分析
Oncotarget. 2016 Aug 9;7(32):51069-51081. doi: 10.18632/oncotarget.9714.
2
[Comparison of three lymph node staging systems in predicting overall survival for gastric cancer patients after radical resection].[三种淋巴结分期系统对胃癌根治术后患者总生存预测的比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Oct 25;19(10):1107-1112.
3
Lymph node ratio-based staging system for esophageal squamous cell carcinoma.基于淋巴结比率的食管鳞状细胞癌分期系统
World J Gastroenterol. 2015 Jun 28;21(24):7514-21. doi: 10.3748/wjg.v21.i24.7514.
4
Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.无论检查的淋巴结数量多少,淋巴结比率都是可切除(R0)胃癌患者的独立预后因素。
Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9.
5
Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.转移性淋巴结比率作为胃癌TNM分期系统的辅助工具的预后价值。
Eur J Surg Oncol. 2015 Jul;41(7):927-33. doi: 10.1016/j.ejso.2015.03.225. Epub 2015 Apr 3.
6
Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system.淋巴结比率作为D1切除术后胃癌患者的预后因素。与现行TNM分期系统的比较。
Eur J Surg Oncol. 2017 Jul;43(7):1350-1356. doi: 10.1016/j.ejso.2017.03.013. Epub 2017 Mar 27.
7
Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.胃腺癌根治性切除术后不同淋巴结分期系统的预后性能
Ann Surg. 2015 Dec;262(6):991-8. doi: 10.1097/SLA.0000000000001040.
8
Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.胃癌手术后淋巴结阳性对数优势(LODDS)对预后预测的优越性:中国 7620 例患者的多机构分析。
Surg Today. 2021 Jan;51(1):101-110. doi: 10.1007/s00595-020-02091-7. Epub 2020 Aug 4.
9
A new predictive model combined of tumor size, lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer.一种结合肿瘤大小、淋巴结计数和淋巴管侵犯的新预测模型用于预测淋巴结阴性胃癌患者的生存预后。
Oncotarget. 2016 Nov 1;7(44):72300-72310. doi: 10.18632/oncotarget.11035.
10
Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database.基于淋巴结比率的分期系统与第 7 版 AJCC 系统在胃癌中的比较:来自 SEER 数据库的 18043 例患者的分析。
Ann Surg. 2012 Mar;255(3):478-85. doi: 10.1097/SLA.0b013e31824857e2.

引用本文的文献

1
Evaluation of three lymph node staging systems for prognostic prediction in gastric cancer: A systematic review and meta-analysis.三种淋巴结分期系统对胃癌预后预测的评估:一项系统评价和荟萃分析
World J Gastrointest Oncol. 2025 Mar 15;17(3):98103. doi: 10.4251/wjgo.v17.i3.98103.
2
Lymph Node Yield and Lymph Node Ratio for Prognosis of Long-Term Survival in Gastric Carcinoma.胃癌长期生存预后的淋巴结获取数量及淋巴结比率
Cancers (Basel). 2025 Jan 27;17(3):414. doi: 10.3390/cancers17030414.
3
Separating lymph node stations by the surgeon from the gastric cancer specimen improves the quality of nodal status evaluation.

本文引用的文献

1
Evaluating the relation between patients-related factors and dissected lymph node ratio in gastric cancer.评估胃癌患者相关因素与淋巴结清扫率之间的关系。
Indian J Cancer. 2015 Jan-Mar;52(1):48-51. doi: 10.4103/0019-509X.175559.
2
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
3
Does lymph node ratio affect prognosis in gastroesophageal cancer?淋巴结比率对胃食管癌的预后有影响吗?
外科医生从胃癌标本中分离淋巴结站可提高淋巴结状态评估的质量。
World J Surg Oncol. 2023 Aug 26;21(1):265. doi: 10.1186/s12957-023-03146-y.
4
Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer.拉丁美洲胃癌患者根治性D2胃切除术后的辅助化疗。
Ecancermedicalscience. 2022 May 12;16:1387. doi: 10.3332/ecancer.2022.1387. eCollection 2022.
5
The metastatic lymph node ratio is a better prognostic factor than the number of metastatic limph node after curative resection for gastric cancer.转移性淋巴结比率是比胃癌根治性切除术后转移性淋巴结数量更好的预后因素。
Acta Biomed. 2021 Nov 3;92(5):e2021284. doi: 10.23750/abm.v92i5.9682.
6
Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.用于预测胃癌总生存期的EMT相关基因特征的鉴定
Front Genet. 2021 Jun 24;12:661306. doi: 10.3389/fgene.2021.661306. eCollection 2021.
7
Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.根治性切除术后壶腹癌长期生存的预后因素。
J Gastrointest Cancer. 2021 Sep;52(3):872-881. doi: 10.1007/s12029-020-00479-9.
8
Is Preoperative Fibrinogen Associated with the Survival Prognosis of Gastric Cancer Patients? A Multi-centered, Propensity Score-Matched Retrospective Study.术前纤维蛋白原与胃癌患者的生存预后有关吗?一项多中心、倾向评分匹配的回顾性研究。
World J Surg. 2020 Jan;44(1):213-222. doi: 10.1007/s00268-019-05191-9.
9
Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Based on the Node Ratio Can Further Improve the Capacity of Prognosis Assessment for Gastric Cancer Patients.基于淋巴结比率的改良美国癌症联合委员会肿瘤-淋巴结-转移分期系统可进一步提高胃癌患者预后评估能力。
Front Oncol. 2019 May 3;9:329. doi: 10.3389/fonc.2019.00329. eCollection 2019.
10
Eighth edition of the American Joint Committee on Cancer staging system: are we getting closer to the ideal classification for gastric cancer?美国癌症联合委员会第八版癌症分期系统:我们离胃癌的理想分类更近了吗?
Ann Transl Med. 2019 Mar;7(Suppl 1):S52. doi: 10.21037/atm.2019.03.05.
Am J Surg. 2015 Sep;210(3):443-50. doi: 10.1016/j.amjsurg.2014.12.042. Epub 2015 Apr 24.
4
Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages.不同pT分期胃癌的转移淋巴结比率与预后
Hepatogastroenterology. 2015 Mar-Apr;62(138):507-11.
5
Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.转移性淋巴结比率作为胃癌TNM分期系统的辅助工具的预后价值。
Eur J Surg Oncol. 2015 Jul;41(7):927-33. doi: 10.1016/j.ejso.2015.03.225. Epub 2015 Apr 3.
6
Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients.转移淋巴结比率成功预测西方胃癌患者的预后。
Surg Oncol. 2015 Jun;24(2):84-8. doi: 10.1016/j.suronc.2015.03.001. Epub 2015 Mar 24.
7
Ratio of metastatic to examined lymph nodes is a predictor of mortality in locally advanced gastric cancer treated chemo-radiotherapy.转移性淋巴结与检查的淋巴结的比例是接受放化疗的局部晚期胃癌患者死亡率的一个预测指标。
Hepatogastroenterology. 2014 Oct;61(135):2141-8.
8
Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer.阴性与阳性淋巴结比例在预测胃癌患者预后方面的优越性。
Ann Surg Oncol. 2015 Apr;22(4):1258-66. doi: 10.1245/s10434-014-4121-8. Epub 2014 Oct 16.
9
Lymph Node Ratio-based Staging System Outperforms the Seventh AJCC System for Gastric Cancer: Validation Analysis With National Taiwan University Hospital Cancer Registry.基于淋巴结比率的分期系统在胃癌方面优于美国癌症联合委员会第七版系统:来自台湾大学医院癌症登记处的验证分析
Am J Clin Oncol. 2017 Feb;40(1):35-41. doi: 10.1097/COC.0000000000000110.
10
Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases.淋巴结比率对胃癌而言是比淋巴结状态更好的预后指标:一项138例病例的回顾性研究。
Oncol Lett. 2013 Dec;6(6):1693-1700. doi: 10.3892/ol.2013.1615. Epub 2013 Oct 10.